Maximising the value of your IP
The viability of a potential business sale or acquisition needs careful assessment. IP is a core business asset that should not be overlooked and the quality of the IP can determine whether a deal is a benefit or a liability.
Clarification of the quality and reach of a target acquisition’s IP assets can avoid costly mistakes and identify opportunities to make the best use of the investment.
We are familiar with working with investors, venture capitalists and venture capital (VC) firms, particularly in the life sciences, consumer electronics and communications sectors where the pace of technological innovation has been significant in recent years.
Our IP evaluation and due diligence services include
- IP audits
- Freedom to operate advice
- IP infringement and validity opinions
- IP due diligence
- Licensing advice and identification of new licensees
- IP business model reviews
- Standards participation advice
- IP asset valuation and advice
- IP acquisition and sale
- IP awareness training
- Post investment IP maintenance, protection and strategy
-
Case Study
Supporting innovation in healthcare
Our client, a leading healthcare investment company, takes an active role in developing technologies to deliver transformative healthcare products. We have advised on IP due diligence and freedom to operate matters in respect of a number of spin-out companies, some originating from leading academic institutions. On behalf of our client, we advised one such company on their pending patents in respect of IP-related matters connected with a multimillion fund raising investment.
-
Case Study
Supporting entrepreneurs
Our client is a Dutch venture capital firm set up to finance and support starting entrepreneurs and their technology ventures. We advised on an IP strategy in respect to an investment opportunity for an innovative technology. Our advice assisted the client in evaluating the commercial value of the underlying IP prior to making their investment.
-
Case Study
Bringing a product to market
Our client was considering a huge investment in a developmental antibody based product. We investigated the validity of key patents and freedom to operate. Our report identified all the relevant players in the field and licenses likely to be required in order to bring the product to market. Only with such a correct understanding of the patent stakeholders in the relevant field was our client able to reach a fully informed decision.
